2021
Renal sarcomas: Epidemiology, treatment and outcomes.
Uhlig J, Uhlig A, Deshpande H, Hurwitz M, Humphrey P, Kim K. Renal sarcomas: Epidemiology, treatment and outcomes. Journal Of Clinical Oncology 2021, 39: 362-362. DOI: 10.1200/jco.2021.39.6_suppl.362.Peer-Reviewed Original ResearchPrimitive neuroectodermal tumorRenal sarcomaOverall survivalMalignant rhabdoid tumorSEER databaseSurgical resectionSystemic therapyDistant metastasisTumor diameterSarcoma subtypesIncidence rateRenal malignancyAge-adjusted incidence ratesCox proportional hazards modelMedian tumor diameterAdvanced T stageDifferent histological subtypesProportional hazards modelSolitary fibrous tumorWorse OSAdult patientsFemale predominanceMale predominanceMedian ageOS rates
2009
Cetuximab versus cisplatin concurrent with IMRT in locally advanced head and neck cancer (LAHNC)
Galper S, Deshpande H, Rose M, Decker R. Cetuximab versus cisplatin concurrent with IMRT in locally advanced head and neck cancer (LAHNC). Journal Of Clinical Oncology 2009, 27: e17030-e17030. DOI: 10.1200/jco.2009.27.15_suppl.e17030.Peer-Reviewed Original ResearchOverall survivalCHRT groupLate toxicityMucosal toxicityAcute mucosal toxicityHigher daily doseTumor registry dataOverall treatment timeDefinitive chemoradiationAcute mucositisConcurrent chemoradiationAdvanced headCompliant patientsLess weight lossRandomized studySkin necrosisCisplatin chemoradiationDaily doseDistant metastasisPatient chartsNeck cancerAltered fractionationRadiation fractionationRegistry dataNonsignificant decrease